📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sophos Biotech

1.1 - Company Overview

Sophos Biotech Logo

Sophos Biotech

Headquarter: Italy
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical medicines and drugs for the treatment of mucositis and prostate and breast oncology.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sophos Biotech

Harbor Therapeutics Logo

Harbor Therapeutics

HQ: United States Website
  • Description: Provider of a proprietary class of adrenal steroid hormones developed as novel pharmaceuticals and potential nutraceuticals for human health.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Harbor Therapeutics company profile →
Redx Pharma Logo

Redx Pharma

HQ: United Kingdom Website
  • Description: Provider of drug discovery and development advancing clinical-stage assets Zelasudil (ROCK2 inhibitor for idiopathic pulmonary fibrosis and fibrotic diseases), Zamaporvint (Porcupine inhibitor for Wnt-ligand driven cancer), RXC008 (GI-targeted pan-ROCK for fibrostenotic Crohn's), and a Drug Discovery Engine supporting programs in fibrosis and oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Redx Pharma company profile →
Lin Bioscience Logo

Lin Bioscience

HQ: Taiwan Website
  • Description: Provider of innovative drug therapies addressing unmet medical needs, developing: LBS-008, an oral treatment for dry age-related macular degeneration and Stargardt disease; LBS-007, a CDC7 inhibitor for leukemia and solid tumors; LBS-002, an anti-tubulin therapy for brain tumors that crosses the blood-brain barrier; and LBS-009, an oral therapy for NAFLD and type 2 diabetes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lin Bioscience company profile →
Paion Logo

Paion

HQ: Germany Website
  • Description: Provider of biopharmaceutical products; develops and commercializes drug candidates for diseases or interventions with substantial unmet medical need. Lead compound: remimazolam, an intravenous, ultra-short-acting, controllable benzodiazepine. Portfolio: Byfavo (procedural sedation, general anesthesia); Angiotensin II/GIAPREZA (refractory hypotension in septic or distributive shock); Eravacycline/XERAVA (complicated intra-abdominal infections in adults).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Paion company profile →
NeRRe Therapeutics Logo

NeRRe Therapeutics

HQ: United Kingdom Website
  • Description: Provider of biotechnology R&D focused on clinical and pre-clinical neurokinin receptor antagonists, including Orvepitant, a neurokinin-1 receptor antagonist in development for treating chronic cough associated with idiopathic pulmonary fibrosis (IPF). Founded in 2012 and based in Stevenage, United Kingdom.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeRRe Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sophos Biotech

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sophos Biotech

2.2 - Growth funds investing in similar companies to Sophos Biotech

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sophos Biotech

4.2 - Public trading comparable groups for Sophos Biotech

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sophos Biotech

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sophos Biotech

What does Sophos Biotech do?

Sophos Biotech is a provider of pharmaceutical medicines and drugs for the treatment of mucositis and prostate and breast oncology.

Who are Sophos Biotech's competitors?

Sophos Biotech's competitors and similar companies include Harbor Therapeutics, Redx Pharma, Lin Bioscience, Paion, and NeRRe Therapeutics.

Where is Sophos Biotech headquartered?

Sophos Biotech is headquartered in Italy.

How many employees does Sophos Biotech have?

Sophos Biotech has 1,000 employees 🔒.

When was Sophos Biotech founded?

Sophos Biotech was founded in 2010 🔒.

What sector and industry vertical is Sophos Biotech in?

Sophos Biotech is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sophos Biotech

Who are the top strategic acquirers in Sophos Biotech's sector and industry

Top strategic M&A buyers and acquirers in Sophos Biotech's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sophos Biotech?

Top strategic M&A buyers groups and sectors for Sophos Biotech include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sophos Biotech's sector and industry vertical

Which are the top PE firms investing in Sophos Biotech's sector and industry vertical?

Top PE firms investing in Sophos Biotech's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sophos Biotech's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sophos Biotech's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sophos Biotech's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sophos Biotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sophos Biotech's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sophos Biotech?

The key public trading comparables and valuation benchmarks for Sophos Biotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sophos Biotech for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sophos Biotech with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sophos Biotech's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sophos Biotech with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sophos Biotech's' sector and industry vertical?

Access recent funding rounds and capital raises in Sophos Biotech's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sophos Biotech